Latest filing published 13 Jun 2024 for Kiromic Biopharma, Inc., €1,229.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Pamela Misajon: trading record in brief
Pamela Misajon discloses dealings in Kiromic Biopharma, Inc. to SEC (Form 4). In total, 4 filings cover trades dated from 18 March 2024 to 12 June 2024.
The open-market record is one-sided, with 3 purchases worth €9,521 and not one sale. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Outside the open market, there are 1 share grant.
The median purchase comes to €3,662. Of 3 purchases, 3 formed part of a group of insiders buying within 30 days of each other. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase.
Most recently, on 13 June 2024, the filings show an open-market purchase worth €1,229 in Kiromic Biopharma, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Pamela Misajon
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 410 shares@ US$3.2412.9% of flowCommon StockSEC:0001104659-24-071382:1Canonical exit: 10 Sept 2024 (T+90)
- 1,200 shares@ US$3.3044.2% of flowCommon StockSEC:0001104659-24-071382:0Canonical exit: 10 Sept 2024 (T+90)
- 1,701 shares@ US$2.9355.8% of flowCommon StockSEC:0001104659-24-070883:0Canonical exit: 8 Sept 2024 (T+90)
- 18,000 sharesRestricted Stock AwardSEC:0001104659-24-036804:0
4 of 4 declarations